John Fox

GreenLight Medicines

Founded in 2014, GreenLight Medicines is a biopharmaceutical company focused on researching, developing and licensing molecules from proprietary cannabinoid formulations to target a range of disease areas. GreenLight Medicines develops plant-derived cannabinoid molecules from proprietary strains. The intellectual property portfolio is based on proprietary blends of cannabinoids, novel plant oil extraction processes and cannabis cultivation technologies (hardware and software). GreenLight Medicines will strive to create awareness within our industry, develop environmentally friendly, sustainable medicines, while increasing our shareholder value by developing new markets for our medicines. We aim to create 500 research and development jobs in the next five years.